SEATTLE & TOKYO--(BUSINESS WIRE)--Accium BioSciences, Inc., (Accium) the first U.S. provider of commercial Accelerator Mass Spectrometry (AMS) services, and CMIC Co., Ltd. (CMIC) Japan’s premier pharmaceutical contract research organization, today announced a partnership to offer Exploratory-IND (microdosing) and low-radiation PK/ADME clinical trials services to Japan pharmaceutical clients.
